The Association of EBV and HHV-6 Viral Load with Different NK and CD8 T Cell Subsets in The Acute Phase of Relapsing-Remitting Multiple Sclerosis

Overview

Journal Cell J

Specialty Cell Biology

Date 2021 Dec 23

PMID 34939755

Citations 1

Authors

Zahra Salehi

Masoumeh Beheshti

Bizhan Nomanpour

Pardis Khosravani

Maryam Naseri

Mohammad Ali Sahraian

Maryam Izad

Affiliations

Soon will be listed here.

Abstract

Objective: Epstein-Barr virus (EBV) and Human Herpes virus 6 (HHV-6) are believed to involve in multiple sclerosis (MS) pathogenesis. Natural killer (NK) and CD8 T cells have essential roles in handling viral infections and their phenotypic and functional properties may be influenced following exposure to viral infections. Here, we investigated the association of NK and CD8 T cells subpopulations frequency with EBV and HHV-6 viral load in MS patients.

Materials And Methods: In this case-control study, EBV and HHV-6 viral load were evaluated in plasma of newly diagnosed relapsing-remitting MS (RRMS) patients at relapse phase (n=23), who were not on disease-modifying therapy (DMT), and sex- and age-matched healthy controls (n=19) using real-time polymerase chain reaction (PCR). The frequency of NK and CD8 T cells subsets were assessed by CD27, CD28, CD45RO, CD56, and CD57 markers using flow cytometry.

Results: Despite the increased level of EBV viral load in RRMS patients compared to the control group, there was no statistically significant difference in EBV and HHV-6 copy numbers between the studied groups. In addition, a significant decrease was observed in the percentages of CD56 CD57 and CD56 CD57 CD8 CD45RO- NK cells in RRMS patients in comparison to healthy controls. Analysis of CD8 T cell subsets showed a substantially high proportion of CD27 CD28 CD45RO CD57 CD8 T cells in patients at relapse phase compared to controls. The frequency of NK and T cells subtypes was not associated with EBV and HHV6 plasma viral loads.

Conclusion: These findings further highlight the variation of NK and CD8 T cells subsets frequency in clinically active RRMS patients. Since the composition of cells was not associated with EBV and HHV-6 viral load, perhaps other viral infections may be involved in altered NK and CD8 T cells subpopulation. Larger cohort studies are needed to confirm these results.

Citing Articles

Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment.

Jayaraman S, Jayaraman A Front Neurol. 2022; 13:980758.

PMID: 36313502 PMC: 9614082. DOI: 10.3389/fneur.2022.980758.

References

McKay K, Kwan V, Duggan T, Tremlett H . Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review. Biomed Res Int. 2015; 2015:817238. PMC: 4329850. DOI: 10.1155/2015/817238. View

Strioga M, Pasukoniene V, Characiejus D . CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology. 2011; 134(1):17-32. PMC: 3173691. DOI: 10.1111/j.1365-2567.2011.03470.x. View

Cermelli C, Berti R, Soldan S, Mayne M, Dambrosia J, Ludwin S . High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis. 2003; 187(9):1377-87. DOI: 10.1086/368166. View

Soldan S, Leist T, Juhng K, McFarland H, Jacobson S . Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol. 2000; 47(3):306-13. View

Polman C, Reingold S, Banwell B, Clanet M, Cohen J, Filippi M . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69(2):292-302. PMC: 3084507. DOI: 10.1002/ana.22366. View

Liu G, Fang L, Hjelmstrom P, Gao X . Increased CD8+ central memory T cells in patients with multiple sclerosis. Mult Scler. 2007; 13(2):149-55. DOI: 10.1177/1352458506069246. View

Kurtzke J . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33(11):1444-52. DOI: 10.1212/wnl.33.11.1444. View

Appay V, van Lier R, Sallusto F, Roederer M . Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A. 2008; 73(11):975-83. DOI: 10.1002/cyto.a.20643. View

Salehi Z, Doosti R, Beheshti M, Janzamin E, Sahraian M, Izad M . Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns. PLoS One. 2016; 11(7):e0159565. PMC: 4965085. DOI: 10.1371/journal.pone.0159565. View

10.

Rodriguez-Martin E, Picon C, Costa-Frossard L, Alenda R, Sainz de la Maza S, Roldan E . Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol. 2015; 180(2):243-9. PMC: 4408159. DOI: 10.1111/cei.12580. View

11.

Mentis A, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou G . Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities. Mol Neurobiol. 2017; 54(5):3911-3923. DOI: 10.1007/s12035-017-0530-6. View

12.

Agut H, Bonnafous P, Gautheret-Dejean A . Laboratory and clinical aspects of human herpesvirus 6 infections. Clin Microbiol Rev. 2015; 28(2):313-35. PMC: 4402955. DOI: 10.1128/CMR.00122-14. View

13.

Mimpen M, Smolders J, Hupperts R, Damoiseaux J . Natural killer cells in multiple sclerosis: A review. Immunol Lett. 2020; 222:1-11. DOI: 10.1016/j.imlet.2020.02.012. View

14.

van Lier R, Ten Berge I, Gamadia L . Human CD8(+) T-cell differentiation in response to viruses. Nat Rev Immunol. 2003; 3(12):931-9. DOI: 10.1038/nri1254. View

15.

Marcenaro E, Notarangelo L, Orange J, Vivier E . Editorial: NK Cell Subsets in Health and Disease: New Developments. Front Immunol. 2017; 8:1363. PMC: 5651263. DOI: 10.3389/fimmu.2017.01363. View

16.

Rommer P, Milo R, Han M, Satyanarayan S, Sellner J, Hauer L . Immunological Aspects of Approved MS Therapeutics. Front Immunol. 2019; 10:1564. PMC: 6637731. DOI: 10.3389/fimmu.2019.01564. View

17.

Marastoni D, Buriani A, Pisani A, Crescenzo F, Zuco C, Fortinguerra S . Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study. Front Immunol. 2019; 10:1666. PMC: 6658905. DOI: 10.3389/fimmu.2019.01666. View

18.

Cocuzza C, Piazza F, Musumeci R, Oggioni D, Andreoni S, Gardinetti M . Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis. PLoS One. 2014; 9(4):e94497. PMC: 3983161. DOI: 10.1371/journal.pone.0094497. View

19.

Sam S, Rogers R, Gillani F, Tsongalis G, Kraft C, Caliendo A . Evaluation of a Next-Generation Sequencing Metagenomics Assay to Detect and Quantify DNA Viruses in Plasma from Transplant Recipients. J Mol Diagn. 2021; 23(6):719-731. PMC: 8279015. DOI: 10.1016/j.jmoldx.2021.02.008. View

20.

Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S . Author Correction: Multiple sclerosis. Nat Rev Dis Primers. 2018; 4(1):49. DOI: 10.1038/s41572-018-0050-3. View